Hi, what are you looking for?
Jewish Business News
Search results for "biotech"
Court
Tamir Capital is invested in Proneuron, which successfully sued Teva for abuse of a license for its product.
Business
Board concludes that approach grossly undervalues Mylan, includes Teva stock, and would expose Mylan to a problematic culture and leadership with poor record of...
Business
The US biotech company currently markets its products in Israel through NewPharm.
Business
To be blunt, finding a cure for pancreatic cancer would be difficult to come up with and the expense too high to justify the...
Blogs
The body’s immune system can easily recognize its own cells
The A-List
Carmakers are afraid of Apple. YouTube, Netflix, and Amazon are upending the television industry. Skype, Facebook, Twitter, Snapchat, and others have changed consumers’ notions...
Blogs
In the 22nd Mar 2015 edition of Israel’s good news, the highlights include: · New Israeli electronic lenses automatically focus on what...
Science
New research project examines olive ingredients which may prevent Alzheimer's disease
StartUps
"The completion of the development of our commercial A3AR biomarker test kit comes at a very important time since we plan to use the...
Business
Teva is selling four targeted oncology development programs to Ignyta for 6% of the biotech company.